Financial Highlights: Period Jan – Jun 2010

Sales fell by 4% to Rs.2248 million.  The profit before taxes increases by 53.2% to Rs. 507.4 million. Earnings after taxes increased by 65% to Rs. 338.1 million.  An amount of Rs. 40.9 million was added to the fixed assets during Jan-Jun 2010. The company has investments in Bank Deposits and Liquid funds of Rs. 3106.4 million.

The core of the Pharmaceuticals business comprises of formulations used in the area of cardiovascular, metabolic diseases and vitamins.  Sales in the Pharmaceuticals business sector fell by 13.4% from Rs. 1759.8 million in Jan to Jun 2009 to Rs. 1524.8 million in Jan to Jun 2010.  The Pharmaceuticals sector accounts for 68% of the Company’s total sales.

The Chemicals business comprises of Bulk Pharma Compounds and Specialty Pigments.  Sales in the Chemicals business grew by 24.2% from Rs. 582.3 million in Jan to Jun 2009 to Rs. 723.3 million in Jan to Jun 2010. The Chemicals business sector accounts for 32% of the Company’s total sales.